Mar 5
|
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
|
Mar 5
|
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
|
Mar 4
|
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
|
Mar 4
|
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
|
Mar 4
|
Reasons to Invest in Vertex Pharmaceuticals Incorporated (VRTX)
|
Feb 17
|
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.
|
Feb 17
|
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now
|
Feb 16
|
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
|
Feb 15
|
Giving Uber Its Due
|
Feb 15
|
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
|
Feb 15
|
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
|
Feb 15
|
Insider Sell: EVP Ourania Tatsis Sells 314 Shares of Vertex Pharmaceuticals Inc
|
Feb 14
|
Stock-Split Watch: Is Vertex Pharmaceuticals Next?
|
Feb 14
|
CORRECTED-(OFFICIAL)-Latigo Biotherapeutics raises $135 mln for non-opioid painkillers
|
Feb 13
|
If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today
|
Feb 13
|
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVYâ„¢ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
|
Feb 12
|
2 Healthcare Stocks That Could Help Set You Up for Life
|
Feb 11
|
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
|
Jan 21
|
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
|
Jan 20
|
3 Unstoppable Growth Stocks That Can Make You Richer in 2024
|